No advantage of antimicrobial prophylaxis in AML/MDS/CMML patients treated with azacitidine—a prospective multicenter study by the Polish Adult Leukemia Group

IntroductionInfections represent one of the most frequent causes of death of higher-risk MDS patients, as reported previously also by our group. Azacitidine Infection Risk Model (AIR), based on red blood cell (RBC) transfusion dependency, neutropenia <0.8 × 109/L, platelet count <50 × 109/L, a...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Krzysztof Mądry, Karol Lis, Elzbieta Sienkiewicz, Joanna Drozd-Sokołowska, Przemysław Biecek, Oktawia Sośnia, Aleksandra Gołos, Magdalena Olszewska-Szopa, Agata Obara, Zuzanna Walkowiak, Joanna Ściesińska, Edyta Subocz, Aleksandra Butrym, Rafał Machowicz, Katarzyna Budziszewska, Grzegorz Basak
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2024-06-01
Edice:	Frontiers in Oncology
Témata:	azacitidine infection myelodysplastic syndromes acute myeloid leukemia chronic myelomonocytic leukemia infection prevention
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1404322/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!